Vertex Pharmaceuticals Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Vertex Pharmaceuticals and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 5400 Vertex Pharmaceuticals employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Vertex Pharmaceuticals has purchased the following applications: MicroStrategy ONE Analytics for Analytics and BI in 2015, Kofax MarkView for AP Automation in 2014, Infinite BrassRing ( Formerly IBM Kenexa BrassRing ) for Applicant Tracking System in 2013 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Vertex Pharmaceuticals is running and its propensity to invest more and deepen its relationship with MicroStrategy , Oracle , Kofax or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Vertex Pharmaceuticals revenues, which have grown to $9.87 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Vertex Pharmaceuticals intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.